Short Interest Worth Mentioning: What’s Utah Medical Products Incorporated (NASDAQ:UTMD) Upside After This Short Interest Decrease?

November 18, 2016 - By Ellis Scott   ·   0 Comments

Short Interest Worth Mentioning: What's Utah Medical Products Incorporated (NASDAQ:UTMD) Upside After This Short Interest Decrease?

The stock of Utah Medical Products Incorporated (NASDAQ:UTMD) registered a decrease of 0.32% in short interest. UTMD’s total short interest was 63,000 shares in November as published by FINRA. Its down 0.32% from 63,200 shares, reported previously. With 4,900 shares average volume, it will take short sellers 13 days to cover their UTMD’s short positions. The short interest to Utah Medical Products Incorporated’s float is 1.99%. About 3,784 shares traded hands. Utah Medical Products, Inc. (NASDAQ:UTMD) has risen 4.82% since April 18, 2016 and is uptrending. It has outperformed by 0.39% the S&P500.

Utah Medical Products, Inc. is engaged in the business of producing medical devices that are disposable and for hospital use. The company has a market cap of $247.31 million. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. It has a 19.7 P/E ratio.

Insitutional Activity: The institutional sentiment decreased to 1.5 in 2016 Q2. Its down 0.40, from 1.9 in 2016Q1. The ratio turned negative, as 2 funds sold all Utah Medical Products, Inc. shares owned while 19 reduced positions. 11 funds bought stakes while 29 increased positions. They now own 2.27 million shares or 0.17% less from 2.27 million shares in 2016Q1.
American Int Grp Incorporated has invested 0% of its portfolio in Utah Medical Products, Inc. (NASDAQ:UTMD). Tower Rech Ltd Liability (Trc), a New York-based fund reported 500 shares. Penobscot Investment Company Inc accumulated 4,000 shares or 0.09% of the stock. The California-based Schwab Charles Management has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Gsa Prtnrs Ltd Liability Partnership holds 4,100 shares or 0.01% of its portfolio. Ny State Common Retirement Fund has 4,000 shares for 0% of their US portfolio. Price T Rowe Associates Inc Md, a Maryland-based fund reported 304,800 shares. Ativo Capital Management Llc last reported 0.23% of its portfolio in the stock. Numeric Limited Liability Company holds 0% or 4,105 shares in its portfolio. Sei Invests Company holds 1,255 shares or 0% of its portfolio. Fmr Ltd accumulated 0% or 470,889 shares. Dimensional Fund L P has invested 0.01% of its portfolio in Utah Medical Products, Inc. (NASDAQ:UTMD). Deutsche Retail Bank Ag has 0% invested in the company for 7,988 shares. The California-based Menta Cap Lc has invested 0.04% in Utah Medical Products, Inc. (NASDAQ:UTMD). The New Jersey-based Blackrock Inv Mgmt Limited Liability Corp has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD).

Insider Transactions: Since May 25, 2016, the stock had 0 insider buys, and 9 insider sales for $546,480 net activity. 23 shares were sold by CORNWELL KEVIN L, worth $1,472 on Monday, August 15. HOYER ERNST G sold $4,020 worth of stock or 63 shares. $17,691 worth of shares were sold by RICHINS PAUL O on Wednesday, May 25.

UTMD Company Profile

Utah Medical Products, Inc. (UTMD), incorporated on April 21, 1978, is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics; neonatal intensive care; gynecology/urology/electrosurgery, and blood pressure monitoring. UTMD markets a range of medical devices used in care areas, such as the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women’s health center in hospitals, as well as products sold to outpatient clinics and physician’s offices. Domestically, UTMD’s medical devices are sold directly to clinical end user facilities by the Company’s own direct sales representatives and independent manufacturers’ representatives. In addition, some of UTMD’s devices are sold through specialty distributors, national hospital distribution companies and other medical device manufacturers. Internationally, products are sold directly to end users in the United Kingdom, Ireland and Australia, and through other medical device companies and through independent medical products distributors in other countries.

Another recent and important Utah Medical Products, Inc. (NASDAQ:UTMD) news was published by Reuters.com which published an article titled: “BRIEF-Utah Medical Products Inc increases quarterly dividend by 2 pct to $…” on November 01, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Ellis Scott


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>